CHAPTER 200-N EPINEPHRINE ADMINISTRATION IN POSTSECONDARY EDUCATIONAL INSTITUTIONS AND INDEPENDENT SCHOOLS
Section 200-N:1
200-N:1 Definitions. –
In this chapter:
I. "Anaphylaxis" means a rapidly progressing, life-threatening allergic reaction that can occur following exposure to certain allergens, most commonly, but not limited to, foods, insect stings, medications, and latex. Signs and symptoms of anaphylaxis include, but are not limited to, difficulty breathing, coughing, throat clearing, altered heart rhythms, hives, redness or blotches on the skin, nausea and vomiting, low blood pressure, shock, and loss of consciousness. Failure to treat these symptoms promptly, with epinephrine, may result in serious consequences up to and including death.
II. "Independent school" means a school which is governed by a board of trustees or other officials who are not publicly elected. An independent school shall not include a chartered public school established pursuant to RSA 194-B, but shall include a private school as provided in Ed 401.01(d).
III. "Licensed campus medical professional" means any of the following individuals who are employed by or have contracted with a postsecondary educational institution or an independent school and are designated by the postsecondary educational institution or independent school to serve in such a capacity:
(a) A physician licensed under RSA 329.
(b) A physician assistant licensed under RSA 328-D.
(c) An advanced practice registered nurse or registered nurse who is licensed under RSA 326-B.
IV. "Member of the campus community" means an individual who is a student, faculty member, or staff member of a postsecondary educational institution or an independent school.
V. "Trained designee" means a member of the campus community trained by a licensed campus medical professional in the emergency administration of auto-injectable epinephrine.
Source. 2015, 45:1, eff. July 17, 2015. 2016, 42:1, eff. July 2, 2016.